You are here

Pardes Biosciences

Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail

Fierce Biotech

Mon, 07/17/23 - 09:34 am

Pardes Biosciences

Biotech launched during Covid — for Covid — looks for strategic alternatives after antiviral fails PhII trial

Endpoints

Mon, 04/3/23 - 10:42 pm

Pardes Biosciences

Pardes initiates Phase II trial of Covid-19 antiviral drug

Clinical Trials Arena

Wed, 09/14/22 - 09:50 am

Pardes Biosciences

Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal

BioPharma Dive

Wed, 06/30/21 - 12:11 am

Gilead Sciences

Pardes Biosciences